Neogenomics Inc.

NASDAQ:NEO   4:00:00 PM EDT
7.31
+0.13 (+1.81%)
7:29:46 PM EDT: $7.48 +0.17 (+2.33%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)940.75M
Current PEN/A
Forward PE 48.73
2yr Forward PE 24.37
See more stats
Estimates Current Quarter
Revenue$183.05 Million
Adjusted EPS$0.03
See more estimates
10-Day MA$7.21
50-Day MA$7.82
200-Day MA$12.32
See more pivots

Neogenomics Inc. Stock, NASDAQ:NEO

9490 NeoGenomics Way, Suite 9, Fort Myers, Florida 33912
United States of America
Phone: +1.239.768.0600
Number of Employees: 2200

Description

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.